Scrolling Therapy, Eurofarma (Brazil)
A digital tool that enables Parkinson’s patients to control their social media feeds using facial therapy exercises
Brief Description
Eurofarma, a Brazilian-based multinational pharmaceutical corporation operating in 22 countries, launched a new facial expression recognition experimental tool powered by artificial intelligence that enables patients with Parkinson’s disease to control their social media engagement using facial expressions.
Why is it significant?
This is an innovative experimental digital tool that involves Parkinson’s patients, raises awareness for the condition, and sparks conversation.
Nowadays, 8.5 million people worldwide are affected by Parkinson’s disease. In addition to any medical treatment, patients need to undergo physical therapy to slow the progression of symptoms of neurological disease.